Long-term Clinical Follow-up of Patients with A3243G Mitochondrial tRNA Mutation : Clinical Phenotype and Natural Course.
- Author:
Mi Sun AHN
1
;
Woo Chul JEOUNG
;
Jin Soon HWANG
;
Sung Hwan KIM
Author Information
1. Department of Pediatrics, School of Medicine, Ajou University Suwon, Korea. pedkim@ajou.ac.kr
- Publication Type:Original Article
- Keywords:
Mitochondrial disorder;
A3243G mutation;
Initial symptom;
Natural history
- MeSH:
Brain;
Cardiomyopathies;
Dementia;
Diabetes Mellitus;
Disease Progression;
Follow-Up Studies*;
Headache;
Hearing Loss, Sensorineural;
Humans;
Magnetic Resonance Imaging;
Mitochondrial Diseases;
Muscular Diseases;
Natural History;
Neurologic Manifestations;
Ophthalmoplegia;
Phenotype*;
RNA, Transfer*;
Seizures
- From:
Journal of the Korean Child Neurology Society
2006;14(2):215-223
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE:Mitochondrial disorder is a progressive disease, but there are no specific treatment modalities to prevent the progression. Also, there has been little understanding on the pattern of disease progression nor natural history. The aim of this study was to elucidate the initial clinical phenotypes, patterns of the disease progression, and its natural history of the patients with mitochondrial A3243G mutation. METHODS:Among the patients with biochemically or genetically confirmed mitochondrial disorders, 7 patients with A3243G mutation were included in a 7 year follow-up observation(range: 3-11 years). We classified the patients into two groups by the initial clinical presentations:systemic and neurologic onset. They were clinically evaluated with serial brain MRI and MRS for the evaluation of the disease evolution patterns. RESULTS:The clinical manifestations of mitochondrial A3243G mutation were extremely variable; seizure, headache, dementia, myopathy, sensorineural hearing loss, external ophthalmoplegia, diabetes mellitus, cardiomyopathy, easy fatigability, and short stature. Among the 7 patients, 4 patients initially presented neurologic symptom such as seizure(3) and headache(1), and 3 patients systemic symptoms such as DM(2) and easy fatigability(1). All the patients with neurologic onset showed relentless progression with recurrent stroke- like episodes and intractable seizures, and finally fell into be functionally dependent states or death. All the patients with systemic onset showed clinically silent periods for 3-10 years, and still they were in functionally independent states despite subsequent neurologic symptoms. CONCLUSION:We could find out the relationship between initial clinical phenotypes and final outcomes in mitochondrial A3243G mutation. However, the population is small in this study so that a larger scaled analysis is needed.
